{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:54:52Z","timestamp":1794048892886,"version":"4.8.0"},"reference-count":263,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-026-00688-9","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:01:32Z","timestamp":1773302492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Tuberous sclerosis complex"],"prefix":"10.1038","volume":"12","author":[{"given":"Kellen","family":"Winden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Martina","family":"Bebin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafali","family":"Jeste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy A.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahna","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7044-2953","authenticated-orcid":false,"given":"Mustafa","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"688_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske, E. P., Jozwiak, S., Kingswood, J. C., Sampson, J. R. & Thiele, E. A. Tuberous sclerosis complex. Nat. Rev. Dis. Primers 2, 16035 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"688_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0553-5","volume":"12","author":"JC Kingswood","year":"2017","unstructured":"Kingswood, J. C. et al. TuberOus SClerosis registry to increase disease awareness (TOSCA) - baseline data on 2093 patients. Orphanet J. Rare Dis. 12, 2 (2017).","journal-title":"Orphanet J. Rare Dis."},{"key":"688_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","volume":"9","author":"KS Au","year":"2007","unstructured":"Au, K. S. et al. Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet. Med. 9, 88\u2013100 (2007).","journal-title":"Genet. Med."},{"key":"688_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15816","volume":"8","author":"KR Martin","year":"2017","unstructured":"Martin, K. R. et al. The genomic landscape of tuberous sclerosis complex. Nat. Commun. 8, 15816 (2017). This study investigates the second hits in TSC1 and TSC2 genes in different hamartomas associated with this disease.","journal-title":"Nat. Commun."},{"key":"688_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adw4165","volume":"18","author":"K Wang","year":"2025","unstructured":"Wang, K., Lockwood, S. E. & Manning, B. D. Evolution of growth factor signaling to the TSC complex to regulate mTORC1. Sci. Signal. 18, eadw4165 (2025).","journal-title":"Sci. Signal."},{"key":"688_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","volume":"84","author":"JO Lipton","year":"2014","unstructured":"Lipton, J. O. & Sahin, M. The neurology of mTOR. Neuron 84, 275\u2013291 (2014).","journal-title":"Neuron"},{"key":"688_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0870-y","volume":"13","author":"D Ebrahimi-Fakhari","year":"2018","unstructured":"Ebrahimi-Fakhari, D. et al. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J. Rare Dis. 13, 117 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"688_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne, J. P., Fryer, A. & Webb, D. Epidemiology of tuberous sclerosis. Ann. NY Acad. Sci. 615, 125\u2013127 (1991).","journal-title":"Ann. NY Acad. Sci."},{"key":"688_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1212\/WNL.35.4.600","volume":"35","author":"WC Wiederholt","year":"1985","unstructured":"Wiederholt, W. C., Gomez, M. R. & Kurland, L. T. Incidence and prevalence of tuberous sclerosis in Rochester, Minnesota, 1950 through 1982. Neurology 35, 600\u2013603 (1985).","journal-title":"Neurology"},{"key":"688_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/archneur.1994.00540130110018","volume":"51","author":"G Ahlsen","year":"1994","unstructured":"Ahlsen, G., Gillberg, I. C., Lindblom, R. & Gillberg, C. Tuberous sclerosis in Western Sweden. A population study of cases with early childhood onset. Arch. Neurol. 51, 76\u201381 (1994).","journal-title":"Arch. Neurol."},{"key":"688_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/epi4.12636","volume":"7","author":"F Fagnani","year":"2022","unstructured":"Fagnani, F., Laurendeau, C., de Zelicourt, M. & Marshall, J. Epidemiology and disease burden of tuberous sclerosis complex in France: a population-based study based on national health insurance data. Epilepsia Open\u00a07, 633\u2013644 (2022).","journal-title":"Epilepsia Open"},{"key":"688_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1513619","volume":"11","author":"O Hagon-Nicod","year":"2024","unstructured":"Hagon-Nicod, O. et al. Tuberous sclerosis: a survey in the canton of Vaud, Switzerland. Front. Med. 11, 1513619 (2024).","journal-title":"Front. Med."},{"key":"688_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03799-w","volume":"20","author":"S Kishida","year":"2025","unstructured":"Kishida, S. et al. Epidemiological insights and healthcare challenges of tuberous sclerosis complex in Shizuoka Prefecture: a retrospective cohort study. Orphanet J. Rare Dis. 20, 245 (2025).","journal-title":"Orphanet J. Rare Dis."},{"key":"688_CR14","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","volume":"351","author":"FJ O\u2019Callaghan","year":"1998","unstructured":"O\u2019Callaghan, F. J., Shiell, A. W., Osborne, J. P. & Martyn, C. N. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 351, 1490 (1998).","journal-title":"Lancet"},{"key":"688_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.seizure.2021.06.027","volume":"91","author":"A Strzelczyk","year":"2021","unstructured":"Strzelczyk, A. et al. Epidemiology, healthcare resource use, and mortality in patients with tuberous sclerosis complex: a population-based study on German health insurance data. Seizure 91, 287\u2013295 (2021).","journal-title":"Seizure"},{"key":"688_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1469-8749.1996.tb12086.x","volume":"38","author":"DW Webb","year":"1996","unstructured":"Webb, D. W., Fryer, A. E. & Osborne, J. P. Morbidity associated with tuberous sclerosis: a population study. Dev. Med. Child Neurol. 38, 146\u2013155 (1996).","journal-title":"Dev. Med. Child Neurol."},{"key":"688_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.seizure.2017.10.005","volume":"53","author":"KO Welin","year":"2017","unstructured":"Welin, K. O. et al. Epilepsy in tuberous sclerosis patients in Sweden \u2014 Healthcare utilization, treatment, morbidity, and mortality using national register data. Seizure 53, 4\u20139 (2017).","journal-title":"Seizure"},{"key":"688_CR18","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1111\/epi.18029","volume":"65","author":"K Barbour","year":"2024","unstructured":"Barbour, K. et al. Population-based study of rare epilepsy incidence in a US urban population. Epilepsia 65, 2341\u20132353 (2024).","journal-title":"Epilepsia"},{"key":"688_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans, D. G. et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am. J. Med. Genet. A 152A, 327\u2013332 (2010).","journal-title":"Am. J. Med. Genet. A"},{"key":"688_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/jmg.26.1.28","volume":"26","author":"JR Sampson","year":"1989","unstructured":"Sampson, J. R., Scahill, S. J., Stephenson, J. B., Mann, L. & Connor, J. M. Genetic aspects of tuberous sclerosis in the west of Scotland. J. Med. Genet. 26, 28\u201331 (1989).","journal-title":"J. Med. Genet."},{"key":"688_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"AC Jones","year":"1999","unstructured":"Jones, A. C. et al. Comprehensive mutation analysis of TSC1 and TSC2 \u2014 and phenotypic correlations in 150 families with tuberous sclerosis. Am. J. Hum. Genet. 64, 1305\u20131315 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"688_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora, S. L. et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet. 68, 64\u201380 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"688_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev-genom-083118-015354","volume":"20","author":"CL Salussolia","year":"2019","unstructured":"Salussolia, C. L., Klonowska, K., Kwiatkowski, D. J. & Sahin, M. Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex. Annu. Rev. Genomics Hum. Genet. 20, 217\u2013240 (2019).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"688_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2023.101086","volume":"47","author":"P Curatolo","year":"2023","unstructured":"Curatolo, P., Trivisano, M. & Specchio, N. Updated genotype\u2013phenotype correlations in TSC. Semin. Pediatr. Neurol. 47, 101086 (2023).","journal-title":"Semin. Pediatr. Neurol."},{"key":"688_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.spen.2015.10.002","volume":"22","author":"P Curatolo","year":"2015","unstructured":"Curatolo, P., Moavero, R., Roberto, D. & Graziola, F. Genotype\/phenotype correlations in tuberous sclerosis complex. Semin. Pediatr. Neurol. 22, 259\u2013273 (2015).","journal-title":"Semin. Pediatr. Neurol."},{"key":"688_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ajmg.a.38083","volume":"173","author":"LS Farach","year":"2017","unstructured":"Farach, L. S. et al. TSC2 c.1864C>T variant associated with mild cases of tuberous sclerosis complex. Am. J. Med. Genet. A 173, 771\u2013775 (2017).","journal-title":"Am. J. Med. Genet. A"},{"key":"688_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ana.21037","volume":"60","author":"AC Jansen","year":"2006","unstructured":"Jansen, A. C. et al. Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann. Neurol. 60, 528\u2013539 (2006).","journal-title":"Ann. Neurol."},{"key":"688_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-0004.2011.01648.x","volume":"81","author":"M Wentink","year":"2012","unstructured":"Wentink, M. et al. Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds. Clin. Genet. 81, 453\u2013461 (2012).","journal-title":"Clin. Genet."},{"key":"688_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup, H. & Krueger, D. A.International Tuberous Sclerosis Complex Consensus Group Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr. Neurol. 49, 243\u2013254 (2013).","journal-title":"Pediatr. Neurol."},{"key":"688_CR30","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-4040","volume":"140","author":"PE Davis","year":"2017","unstructured":"Davis, P. E. et al. Presentation and diagnosis of tuberous sclerosis complex in infants. Pediatrics 140, e20164040 (2017).","journal-title":"Pediatrics"},{"key":"688_CR31","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/s41431-024-01631-w","volume":"32","author":"V Milon","year":"2024","unstructured":"Milon, V. et al. Diagnosis of tuberous sclerosis in the prenatal period: a retrospective study of 240 cases and review of the literature. Eur. J. Hum. Genet. 32, 1590\u20131598 (2024).","journal-title":"Eur. J. Hum. Genet."},{"key":"688_CR32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","volume":"9","author":"C McCarthy","year":"2021","unstructured":"McCarthy, C., Gupta, N., Johnson, S. R., Yu, J. J. & McCormack, F. X. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir. Med. 9, 1313\u20131327 (2021).","journal-title":"Lancet Respir. Med."},{"key":"688_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00972","volume":"11","author":"JC Kingswood","year":"2020","unstructured":"Kingswood, J. C. et al. Renal manifestations of tuberous sclerosis complex: key findings from the final analysis of the TOSCA study focussing mainly on renal angiomyolipomas. Front. Neurol. 11, 972 (2020).","journal-title":"Front. Neurol."},{"key":"688_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7202a1","volume":"72","author":"MJ Maenner","year":"2023","unstructured":"Maenner, M. J. et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years \u2014 Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020. MMWR Surveill. Summ. 72, 1\u201314 (2023).","journal-title":"MMWR Surveill. Summ."},{"key":"688_CR35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/dmcn.14787","volume":"63","author":"RA Mitchell","year":"2021","unstructured":"Mitchell, R. A., Barton, S. M., Harvey, A. S., Ure, A. M. & Williams, K. Factors associated with autism spectrum disorder in children with tuberous sclerosis complex: a systematic review and meta-analysis. Dev. Med. Child Neurol. 63, 791\u2013801 (2021).","journal-title":"Dev. Med. Child Neurol."},{"key":"688_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/dmcn.13352","volume":"59","author":"S Amin","year":"2017","unstructured":"Amin, S. et al. Causes of mortality in individuals with tuberous sclerosis complex. Dev. Med. Child Neurol. 59, 612\u2013617 (2017).","journal-title":"Dev. Med. Child Neurol."},{"key":"688_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jir.13225","volume":"69","author":"CRT Kidson","year":"2025","unstructured":"Kidson, C. R. T., Loh, N. R. & Syed, Y. A. Mortality in tuberous sclerosis complex in the United Kingdom, 2016-2022. J. Intellect. Disabil. Res. 69, 457\u2013464 (2025).","journal-title":"J. Intellect. Disabil. Res."},{"key":"688_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108032","volume":"121","author":"S Parthasarathy","year":"2021","unstructured":"Parthasarathy, S., Mahalingam, R., Melchiorre, J., Harowitz, J. & Devinsky, O. Mortality in tuberous sclerosis complex. Epilepsy Behav. 121, 108032 (2021).","journal-title":"Epilepsy Behav."},{"key":"688_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejpn.2025.08.002","volume":"58","author":"R Pentz","year":"2025","unstructured":"Pentz, R. et al. Mortality in tuberous sclerosis complex: current understandings. Eur. J. Paediatr. Neurol. 58, 83\u201391 (2025).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"688_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-021-00130-3","volume":"3","author":"JP Zollner","year":"2021","unstructured":"Zollner, J. P. et al. Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany. Neurol. Res. Pract. 3, 35 (2021).","journal-title":"Neurol. Res. Pract."},{"key":"688_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.yebeh.2008.05.010","volume":"13","author":"CM Kopp","year":"2008","unstructured":"Kopp, C. M., Muzykewicz, D. A., Staley, B. A., Thiele, E. A. & Pulsifer, M. B. Behavior problems in children with tuberous sclerosis complex and parental stress. Epilepsy Behav. 13, 505\u2013510 (2008).","journal-title":"Epilepsy Behav."},{"key":"688_CR42","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.1074\/jbc.C500451200","volume":"281","author":"H Chong-Kopera","year":"2006","unstructured":"Chong-Kopera, H. et al. TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J. Biol. Chem. 281, 8313\u20138316 (2006).","journal-title":"J. Biol. Chem."},{"key":"688_CR43","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.molcel.2021.04.019","volume":"81","author":"K Fitzian","year":"2021","unstructured":"Fitzian, K. et al. TSC1 binding to lysosomal PIPs is required for TSC complex translocation and mTORC1 regulation. Mol. Cell 81, 2705\u20132721.e8 (2021).","journal-title":"Mol. Cell"},{"key":"688_CR44","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829\u20131834 (2003).","journal-title":"Genes Dev."},{"key":"688_CR45","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","volume":"13","author":"AR Tee","year":"2003","unstructured":"Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C. & Blenis, J. Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259\u20131268 (2003).","journal-title":"Curr. Biol."},{"key":"688_CR46","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ncb999","volume":"5","author":"Y Zhang","year":"2003","unstructured":"Zhang, Y. et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5, 578\u2013581 (2003).","journal-title":"Nat. Cell Biol."},{"key":"688_CR47","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature25023","volume":"552","author":"H Yang","year":"2017","unstructured":"Yang, H. et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature 552, 368\u2013373 (2017).","journal-title":"Nature"},{"key":"688_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble, C. C. et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol. Cell 47, 535\u2013546 (2012). This is the identification of the third component of the TSC complex, which binds to TSC1\/TSC2.","journal-title":"Mol. Cell"},{"key":"688_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110824","volume":"39","author":"S Schrotter","year":"2022","unstructured":"Schrotter, S. et al. The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth. Cell Rep. 39, 110824 (2022).","journal-title":"Cell Rep."},{"key":"688_CR50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/humu.22529","volume":"35","author":"AA Alfaiz","year":"2014","unstructured":"Alfaiz, A. A. et al. TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease. Hum. Mutat. 35, 447\u2013451 (2014).","journal-title":"Hum. Mutat."},{"key":"688_CR51","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/jmedgenet-2013-101680","volume":"50","author":"JM Capo-Chichi","year":"2013","unstructured":"Capo-Chichi, J. M. et al. Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly. J. Med. Genet. 50, 740\u2013744 (2013).","journal-title":"J. Med. Genet."},{"key":"688_CR52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1083\/jcb.200507119","volume":"173","author":"SL Cai","year":"2006","unstructured":"Cai, S. L. et al. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J. Cell Biol. 173, 279\u2013289 (2006).","journal-title":"J. Cell Biol."},{"key":"688_CR53","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648\u2013657 (2002).","journal-title":"Nat. Cell Biol."},{"key":"688_CR54","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","volume":"126","author":"K Inoki","year":"2006","unstructured":"Inoki, K. et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955\u2013968 (2006).","journal-title":"Cell"},{"key":"688_CR55","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1073\/pnas.0409143102","volume":"102","author":"BA Ballif","year":"2005","unstructured":"Ballif, B. A. et al. Quantitative phosphorylation profiling of the ERK\/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc. Natl Acad. Sci. USA 102, 667\u2013672 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"688_CR56","doi-asserted-by":"publisher","first-page":"13489","DOI":"10.1073\/pnas.0405659101","volume":"101","author":"PP Roux","year":"2004","unstructured":"Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P. & Blenis, J. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl Acad. Sci. USA 101, 13489\u201313494 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"688_CR57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-019-03498-8","volume":"456","author":"J Zhan","year":"2019","unstructured":"Zhan, J., Chitta, R. K., Harwood, F. C. & Grosveld, G. C. Phosphorylation of TSC2 by PKC-\u03b4 reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity. Mol. Cell Biochem. 456, 123\u2013134 (2019).","journal-title":"Mol. Cell Biochem."},{"key":"688_CR58","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.88318","volume":"12","author":"P Wang","year":"2024","unstructured":"Wang, P. et al. DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity. eLife 12, RP88318 (2024).","journal-title":"eLife"},{"key":"688_CR59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41423-019-0293-2","volume":"18","author":"Z Wei","year":"2021","unstructured":"Wei, Z. et al. DAPK1 (death associated protein kinase 1) mediates mTORC1 activation and antiviral activities in CD8+ T cells. Cell Mol. Immunol. 18, 138\u2013149 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"688_CR60","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","volume":"156","author":"S Menon","year":"2014","unstructured":"Menon, S. et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156, 771\u2013785 (2014).","journal-title":"Cell"},{"key":"688_CR61","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41580-023-00641-8","volume":"24","author":"C Goul","year":"2023","unstructured":"Goul, C., Peruzzo, R. & Zoncu, R. The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Nat. Rev. Mol. Cell Biol. 24, 857\u2013875 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"688_CR62","doi-asserted-by":"publisher","first-page":"12783","DOI":"10.1074\/jbc.M809207200","volume":"284","author":"T Sato","year":"2009","unstructured":"Sato, T., Nakashima, A., Guo, L. & Tamanoi, F. Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J. Biol. Chem. 284, 12783\u201312791 (2009).","journal-title":"J. Biol. Chem."},{"key":"688_CR63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","volume":"10","author":"R Loewith","year":"2002","unstructured":"Loewith, R. et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457\u2013468 (2002).","journal-title":"Mol. Cell"},{"key":"688_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21, 183\u2013203 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"688_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31961-6","volume":"13","author":"V Karalis","year":"2022","unstructured":"Karalis, V., Caval-Holme, F. & Bateup, H. S. Raptor downregulation rescues neuronal phenotypes in mouse models of tuberous sclerosis complex. Nat. Commun. 13, 4665 (2022).","journal-title":"Nat. Commun."},{"key":"688_CR66","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00726-016-2171-x","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim, J. & Kim, E. Rag GTPase in amino acid signaling. Amino Acids 48, 915\u2013928 (2016).","journal-title":"Amino Acids"},{"key":"688_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042068","volume":"25","author":"M Muller","year":"2024","unstructured":"Muller, M. et al. GATOR1 mutations impair PI3 kinase-dependent growth factor signaling regulation of mTORC1. Int. J. Mol. Sci. 25, 2068 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"688_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113432","volume":"334","author":"PH Iffland 2nd","year":"2020","unstructured":"Iffland, P. H. 2nd, Barnes, A. E., Baybis, M. & Crino, P. B. Dynamic analysis of 4E-BP1 phosphorylation in neurons with Tsc2 or Depdc5 knockout. Exp. Neurol. 334, 113432 (2020).","journal-title":"Exp. Neurol."},{"key":"688_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111278","volume":"40","author":"CJ Yuskaitis","year":"2022","unstructured":"Yuskaitis, C. J. et al. DEPDC5-dependent mTORC1 signaling mechanisms are critical for the anti-seizure effects of acute fasting. Cell Rep. 40, 111278 (2022).","journal-title":"Cell Rep."},{"key":"688_CR70","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1091\/mbc.e08-12-1248","volume":"20","author":"N Hosokawa","year":"2009","unstructured":"Hosokawa, N. et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981\u20131991 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"688_CR71","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1091\/mbc.e08-12-1249","volume":"20","author":"CH Jung","year":"2009","unstructured":"Jung, C. H. et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 20, 1992\u20132003 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"688_CR72","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","volume":"31","author":"C Settembre","year":"2012","unstructured":"Settembre, C. et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31, 1095\u20131108 (2012).","journal-title":"EMBO J."},{"key":"688_CR73","first-page":"109","volume":"39","author":"L He","year":"2025","unstructured":"He, L., Cho, S. & Blenis, J. mTORC1, the maestro of cell metabolism and growth. Genes Dev. 39, 109\u2013131 (2025).","journal-title":"Genes Dev."},{"key":"688_CR74","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","volume":"49","author":"J Roth","year":"2013","unstructured":"Roth, J. et al. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr. Neurol. 49, 439\u2013444 (2013).","journal-title":"Pediatr. Neurol."},{"key":"688_CR75","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/jnen\/63.12.1236","volume":"63","author":"JA Chan","year":"2004","unstructured":"Chan, J. A. et al. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J. Neuropathol. Exp. Neurol. 63, 1236\u20131242 (2004).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"688_CR76","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz, D. N. et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 381, 125\u2013132 (2013).","journal-title":"Lancet"},{"key":"688_CR77","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3171\/2011.12.PEDS11418","volume":"9","author":"JS Katz","year":"2012","unstructured":"Katz, J. S. et al. Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus. J. Neurosurg. Pediatr. 9, 406\u2013413 (2012).","journal-title":"J. Neurosurg. Pediatr."},{"key":"688_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00705","volume":"10","author":"AC Jansen","year":"2019","unstructured":"Jansen, A. C. et al. Clinical characteristics of subependymal giant cell astrocytoma in tuberous sclerosis complex. Front. Neurol. 10, 705 (2019).","journal-title":"Front. Neurol."},{"key":"688_CR79","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1007\/s00467-024-06417-2","volume":"39","author":"A Limavady","year":"2024","unstructured":"Limavady, A. & Marlais, M. The extent of kidney involvement in paediatric tuberous sclerosis complex. Pediatr. Nephrol. 39, 2927\u20132937 (2024).","journal-title":"Pediatr. Nephrol."},{"key":"688_CR80","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1086\/321972","volume":"69","author":"Y Niida","year":"2001","unstructured":"Niida, Y. et al. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am. J. Hum. Genet. 69, 493\u2013503 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"688_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006242","volume":"12","author":"K Giannikou","year":"2016","unstructured":"Giannikou, K. et al. Whole exome sequencing identifies TSC1\/TSC2 biallelic loss as the primary and sufficient driver event for renal angiomyolipoma development. PLoS Genet. 12, e1006242 (2016).","journal-title":"PLoS Genet."},{"key":"688_CR82","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","volume":"361","author":"N El-Hashemite","year":"2003","unstructured":"El-Hashemite, N., Zhang, H., Henske, E. P. & Kwiatkowski, D. J. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361, 1348\u20131349 (2003).","journal-title":"Lancet"},{"key":"688_CR83","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00000478-199203000-00013","volume":"16","author":"F Bonetti","year":"1992","unstructured":"Bonetti, F., Pea, M., Martignoni, G. & Zamboni, G. PEC and sugar. Am. J. Surg. Pathol. 16, 307\u2013308 (1992).","journal-title":"Am. J. Surg. Pathol."},{"key":"688_CR84","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pathol.2020.08.008","volume":"53","author":"A Calio","year":"2021","unstructured":"Calio, A. et al. Angiomyolipoma of the kidney: from simple hamartoma to complex tumour. Pathology 53, 129\u2013140 (2021).","journal-title":"Pathology"},{"key":"688_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111048","volume":"40","author":"A Pietrobon","year":"2022","unstructured":"Pietrobon, A., Yockell-Lelievre, J., Flood, T. A. & Stanford, W. L. Renal organoid modeling of tuberous sclerosis complex reveals lesion features arise from diverse developmental processes. Cell Rep. 40, 111048 (2022).","journal-title":"Cell Rep."},{"key":"688_CR86","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2119\/2006-00070.Lim","volume":"13","author":"SD Lim","year":"2007","unstructured":"Lim, S. D. et al. Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells? Mol. Med. 13, 160\u2013165 (2007).","journal-title":"Mol. Med."},{"key":"688_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26596-y","volume":"12","author":"JOR Hernandez","year":"2021","unstructured":"Hernandez, J. O. R. et al. A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo. Nat. Commun. 12, 6496 (2021).","journal-title":"Nat. Commun."},{"key":"688_CR88","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler, J. J. et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 381, 817\u2013824 (2013).","journal-title":"Lancet"},{"key":"688_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226400","volume":"14","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM). PLoS ONE 14, e0226400 (2019).","journal-title":"PLoS ONE"},{"key":"688_CR90","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1164\/ajrccm.164.8.2104095","volume":"164","author":"J Yu","year":"2001","unstructured":"Yu, J., Astrinidis, A. & Henske, E. P. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am. J. Respir. Crit. Care Med. 164, 1537\u20131540 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"688_CR91","doi-asserted-by":"publisher","first-page":"30958","DOI":"10.1074\/jbc.M202678200","volume":"277","author":"EA Goncharova","year":"2002","unstructured":"Goncharova, E. A. et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 gtumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem. 277, 30958\u201330967 (2002).","journal-title":"J. Biol. Chem."},{"key":"688_CR92","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler, J. J. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 358, 140\u2013151 (2008).","journal-title":"N. Engl. J. Med."},{"key":"688_CR93","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1056\/NEJMc072500","volume":"358","author":"DM Davies","year":"2008","unstructured":"Davies, D. M. et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N. Engl. J. Med. 358, 200\u2013203 (2008).","journal-title":"N. Engl. J. Med."},{"key":"688_CR94","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack, F. X. et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N. Engl. J. Med. 364, 1595\u20131606 (2011).","journal-title":"N. Engl. J. Med."},{"key":"688_CR95","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","volume":"97","author":"T Carsillo","year":"2000","unstructured":"Carsillo, T., Astrinidis, A. & Henske, E. P. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 97, 6085\u20136090 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"688_CR96","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1164\/ajrccm.187.6.663","volume":"187","author":"KR Badri","year":"2013","unstructured":"Badri, K. R. et al. Exonic mutations of TSC2\/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis. Am. J. Respir. Crit. Care Med. 187, 663\u2013665 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"688_CR97","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/hupa.2003.50","volume":"34","author":"I Bittmann","year":"2003","unstructured":"Bittmann, I., Rolf, B., Amann, G. & Lohrs, U. Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum. Pathol. 34, 95\u201398 (2003).","journal-title":"Hum. Pathol."},{"key":"688_CR98","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","volume":"167","author":"M Karbowniczek","year":"2003","unstructured":"Karbowniczek, M. et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am. J. Respir. Crit. Care Med. 167, 976\u2013982 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"688_CR99","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1164\/rccm.201912-2445OC","volume":"202","author":"M Guo","year":"2020","unstructured":"Guo, M. et al. Single-cell transcriptomic analysis identifies a unique pulmonary lymphangioleiomyomatosis cell. Am. J. Respir. Crit. Care Med. 202, 1373\u20131387 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"688_CR100","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1378\/chest.117.1.25","volume":"117","author":"H Logginidou","year":"2000","unstructured":"Logginidou, H., Ao, X., Russo, I. & Henske, E. P. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest 117, 25\u201330 (2000).","journal-title":"Chest"},{"key":"688_CR101","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S2213-2600(13)70090-0","volume":"1","author":"L Young","year":"2013","unstructured":"Young, L. et al. Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the multicenter international lymphangioleiomyomatosis efficacy of sirolimus (MILES) trial. Lancet Respir. Med. 1, 445\u2013452 (2013).","journal-title":"Lancet Respir. Med."},{"key":"688_CR102","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0046-8177(97)90061-7","volume":"28","author":"T Hayashi","year":"1997","unstructured":"Hayashi, T. et al. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum. Pathol. 28, 1071\u20131078 (1997).","journal-title":"Hum. Pathol."},{"key":"688_CR103","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1172\/JCI58709","volume":"122","author":"EP Henske","year":"2012","unstructured":"Henske, E. P. & McCormack, F. X. Lymphangioleiomyomatosis \u2014 a wolf in sheep\u2019s clothing. J. Clin. Invest. 122, 3807\u20133816 (2012).","journal-title":"J. Clin. Invest."},{"key":"688_CR104","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0002-9394(14)71174-2","volume":"119","author":"IE Zimmer-Galler","year":"1995","unstructured":"Zimmer-Galler, I. E. & Robertson, D. M. Long-term observation of retinal lesions in tuberous sclerosis. Am. J. Ophthalmol. 119, 318\u2013324 (1995).","journal-title":"Am. J. Ophthalmol."},{"key":"688_CR105","first-page":"139","volume":"102","author":"JA Shields","year":"2004","unstructured":"Shields, J. A., Eagle, R. C. Jr., Shields, C. L. & Marr, B. P. Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex. Trans. Am. Ophthalmol. Soc. 102, 139\u2013147 (2004).","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"688_CR106","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/01658107.2025.2457587","volume":"49","author":"BD Smith","year":"2025","unstructured":"Smith, B. D. et al. Neuro-ophthalmic characteristics of patients with tuberous sclerosis complex at a tertiary care referral centre. Neuroophthalmology 49, 241\u2013248 (2025).","journal-title":"Neuroophthalmology"},{"key":"688_CR107","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001493","volume":"3","author":"RB Hinton","year":"2014","unstructured":"Hinton, R. B. et al. Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group. J. Am. Heart Assoc. 3, e001493 (2014).","journal-title":"J. Am. Heart Assoc."},{"key":"688_CR108","doi-asserted-by":"publisher","first-page":"326","DOI":"10.5507\/bp.2017.023","volume":"161","author":"M Godava","year":"2017","unstructured":"Godava, M. et al. Single giant mediastinal rhabdomyoma as a sole manifestation of TSC in foetus. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 161, 326\u2013329 (2017).","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub."},{"key":"688_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1802","volume":"9","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Detection of TSC1\/TSC2 mosaic variants in patients with cardiac rhabdomyoma and tuberous sclerosis complex by hybrid-capture next-generation sequencing. Mol. Genet. Genomic Med. 9, e1802 (2021).","journal-title":"Mol. Genet. Genomic Med."},{"key":"688_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-04043-8","author":"D Hurtado-Sierra","year":"2025","unstructured":"Hurtado-Sierra, D., Ramos Garzon, J. X., Romero-Guevara, S. L., Serrano-Garcia, A. Y. & Rojas, L. Z. Everolimus and sirolimus in the treatment of cardiac rhabdomyomas in neonates. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-025-04043-8 (2025).","journal-title":"Pediatr. Res."},{"key":"688_CR111","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/hmg\/ddt597","volume":"23","author":"ME Tyburczy","year":"2014","unstructured":"Tyburczy, M. E. et al. Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex. Hum. Mol. Genet. 23, 2023\u20132029 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"688_CR112","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/pde.13204","volume":"34","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Tuberous sclerosis complex in 29 children: clinical and genetic analysis and facial angiofibroma responses to topical sirolimus. Pediatr. Dermatol. 34, 572\u2013577 (2017).","journal-title":"Pediatr. Dermatol."},{"key":"688_CR113","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jaad.2015.07.018","volume":"73","author":"N Nathan","year":"2015","unstructured":"Nathan, N. et al. Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus. J. Am. Acad. Dermatol. 73, 802\u2013808 (2015).","journal-title":"J. Am. Acad. Dermatol."},{"key":"688_CR114","doi-asserted-by":"publisher","first-page":"5S20","DOI":"10.1016\/S0929-693X(22)00286-X","volume":"29","author":"D Farges","year":"2022","unstructured":"Farges, D., Sigg, N., Ville, D. & Martin, L. Use of mTOR inhibitors (rapalogs) for the treatment of skin changes in tuberous sclerosis complex. Arch. Pediatr. 29, 5S20\u20135S24 (2022).","journal-title":"Arch. Pediatr."},{"key":"688_CR115","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamadermatol.2017.0298","volume":"153","author":"MA Bongiorno","year":"2017","unstructured":"Bongiorno, M. A. et al. Clinical characteristics of connective tissue nevi in tuberous sclerosis complex with special emphasis on shagreen patches. JAMA Dermatol. 153, 660\u2013665 (2017).","journal-title":"JAMA Dermatol."},{"key":"688_CR116","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jaad.2010.03.002","volume":"64","author":"D Ma","year":"2011","unstructured":"Ma, D., Darling, T., Moss, J. & Lee, C. C. Histologic variants of periungual fibromas in tuberous sclerosis complex. J. Am. Acad. Dermatol. 64, 442\u2013444 (2011).","journal-title":"J. Am. Acad. Dermatol."},{"key":"688_CR117","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1528-1167.2008.01814.x","volume":"50","author":"P Major","year":"2009","unstructured":"Major, P. et al. Are cortical tubers epileptogenic? Evidence from electrocorticography. Epilepsia 50, 147\u2013154 (2009).","journal-title":"Epilepsia"},{"key":"688_CR118","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1212\/WNL.0b013e3182768923","volume":"79","author":"AR Mohamed","year":"2012","unstructured":"Mohamed, A. R. et al. Intrinsic epileptogenicity of cortical tubers revealed by intracranial EEG monitoring. Neurology 79, 2249\u20132257 (2012).","journal-title":"Neurology"},{"key":"688_CR119","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/08830738040190090501","volume":"19","author":"K Ridler","year":"2004","unstructured":"Ridler, K., Suckling, J., Higgins, N., Bolton, P. & Bullmore, E. Standardized whole brain mapping of tubers and subependymal nodules in tuberous sclerosis complex. J. Child Neurol. 19, 658\u2013665 (2004).","journal-title":"J. Child Neurol."},{"key":"688_CR120","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3174\/ajnr.A3260","volume":"34","author":"J Vaughn","year":"2013","unstructured":"Vaughn, J. et al. MRI characterization and longitudinal study of focal cerebellar lesions in a young tuberous sclerosis cohort. AJNR Am. J. Neuroradiol. 34, 655\u2013659 (2013).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"688_CR121","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.26015","volume":"89","author":"AL Cohen","year":"2021","unstructured":"Cohen, A. L. et al. Tuber locations associated with infantile spasms map to a common brain network. Ann. Neurol. 89, 726\u2013739 (2021). Analysis of a large prospective cohort of infants born with TSC revealing that globus pallidus connectivity of the cortical tuber locations is a strong predictor of infantile spasms.","journal-title":"Ann. Neurol."},{"key":"688_CR122","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1440-1789.2008.00920.x","volume":"28","author":"K Boer","year":"2008","unstructured":"Boer, K. et al. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology 28, 577\u2013590 (2008).","journal-title":"Neuropathology"},{"key":"688_CR123","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/WNL.0b013e3181e04325","volume":"74","author":"PB Crino","year":"2010","unstructured":"Crino, P. B., Aronica, E., Baltuch, G. & Nathanson, K. L. Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology 74, 1716\u20131723 (2010).","journal-title":"Neurology"},{"key":"688_CR124","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French, J. A. et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 388, 2153\u20132163 (2016). Large multicentre study that established the efficacy of everolimus in TSC-associated epilepsy.","journal-title":"Lancet"},{"key":"688_CR125","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1212\/WNL.0000000000003077","volume":"87","author":"IE Overwater","year":"2016","unstructured":"Overwater, I. E. et al. Sirolimus for epilepsy in children with tuberous sclerosis complex: a randomized controlled trial. Neurology 87, 1011\u20131018 (2016).","journal-title":"Neurology"},{"key":"688_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-neuro-080317-061747","volume":"41","author":"KD Winden","year":"2018","unstructured":"Winden, K. D., Ebrahimi-Fakhari, D. & Sahin, M. Abnormal mTOR activation in autism. Annu. Rev. Neurosci. 41, 1\u201323 (2018).","journal-title":"Annu. Rev. Neurosci."},{"key":"688_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0347-3","volume":"8","author":"N Grabole","year":"2016","unstructured":"Grabole, N. et al. Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model. Genome Med. 8, 94 (2016).","journal-title":"Genome Med."},{"key":"688_CR128","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41591-018-0139-y","volume":"24","author":"JD Blair","year":"2018","unstructured":"Blair, J. D., Hockemeyer, D. & Bateup, H. S. Genetically engineered human cortical spheroid models of tuberous sclerosis. Nat. Med. 24, 1568\u20131578 (2018). This is one of the first examples of modelling TSC brain lesions using human stem cell-derived organoids.","journal-title":"Nat. Med."},{"key":"688_CR129","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ana.21342","volume":"63","author":"DM Talos","year":"2008","unstructured":"Talos, D. M., Kwiatkowski, D. J., Cordero, K., Black, P. M. & Jensen, F. E. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann. Neurol. 63, 454\u2013465 (2008).","journal-title":"Ann. Neurol."},{"key":"688_CR130","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nbd.2016.07.014","volume":"95","author":"G Ruffolo","year":"2016","unstructured":"Ruffolo, G. et al. Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions. Neurobiol. Dis. 95, 93\u2013101 (2016).","journal-title":"Neurobiol. Dis."},{"key":"688_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147273","volume":"22","author":"D Bassetti","year":"2021","unstructured":"Bassetti, D., Luhmann, H. J. & Kirischuk, S. Effects of mutations in TSC genes on neurodevelopment and synaptic transmission. Int. J. Mol. Sci. 22, 7273 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"688_CR132","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1523\/JNEUROSCI.4796-14.2015","volume":"35","author":"D Nie","year":"2015","unstructured":"Nie, D. et al. The stress-induced Atf3-gelsolin cascade underlies dendritic spine deficits in neuronal models of tuberous sclerosis complex. J. Neurosci. 35, 10762\u201310772 (2015).","journal-title":"J. Neurosci."},{"key":"688_CR133","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/npp.2017.295","volume":"43","author":"E Kelly","year":"2018","unstructured":"Kelly, E. et al. mGluR5 modulation of behavioral and epileptic phenotypes in a mouse model of tuberous sclerosis complex. Neuropsychopharmacology 43, 1457\u20131465 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"688_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-023-00572-3","volume":"14","author":"IS Aksoylu","year":"2023","unstructured":"Aksoylu, I. S. et al. Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations. Mol. Autism 14, 39 (2023).","journal-title":"Mol. Autism"},{"key":"688_CR135","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.celrep.2016.02.090","volume":"15","author":"V Costa","year":"2016","unstructured":"Costa, V. et al. mTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis. Cell Rep. 15, 86\u201395 (2016).","journal-title":"Cell Rep."},{"key":"688_CR136","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67399","volume":"10","author":"JS Dalal","year":"2021","unstructured":"Dalal, J. S. et al. Loss of Tsc1 in cerebellar Purkinje cells induces transcriptional and translation changes in FMRP target transcripts. eLife 10, e67399 (2021).","journal-title":"eLife"},{"key":"688_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112838","volume":"42","author":"KD Winden","year":"2023","unstructured":"Winden, K. D. et al. Increased degradation of FMRP contributes to neuronal hyperexcitability in tuberous sclerosis complex. Cell Rep. 42, 112838 (2023).","journal-title":"Cell Rep."},{"key":"688_CR138","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41380-018-0018-4","volume":"23","author":"M Sundberg","year":"2018","unstructured":"Sundberg, M. et al. Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin. Mol. Psychiatry 23, 2167\u20132183 (2018).","journal-title":"Mol. Psychiatry"},{"key":"688_CR139","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.20160446","volume":"214","author":"E Ercan","year":"2017","unstructured":"Ercan, E. et al. Neuronal CTGF\/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex. J. Exp. Med. 214, 681\u2013697 (2017).","journal-title":"J. Exp. Med."},{"key":"688_CR140","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1523\/JNEUROSCI.0642-19.2019","volume":"39","author":"KD Winden","year":"2019","unstructured":"Winden, K. D. et al. Biallelic mutations in TSC2 lead to abnormalities associated with cortical tubers in human iPSC-derived neurons. J. Neurosci. 39, 9294\u20139305 (2019).","journal-title":"J. Neurosci."},{"key":"688_CR141","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/nn1566","volume":"8","author":"SF Tavazoie","year":"2005","unstructured":"Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J. & Sabatini, B. L. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 8, 1727\u20131734 (2005).","journal-title":"Nat. Neurosci."},{"key":"688_CR142","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.neuron.2014.07.040","volume":"83","author":"G Tang","year":"2014","unstructured":"Tang, G. et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 83, 1131\u20131143 (2014).","journal-title":"Neuron"},{"key":"688_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12962-4","volume":"10","author":"R Malik","year":"2019","unstructured":"Malik, R. et al. Tsc1 represses parvalbumin expression and fast-spiking properties in somatostatin lineage cortical interneurons. Nat. Commun. 10, 4994 (2019).","journal-title":"Nat. Commun."},{"key":"688_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-020-00340-7","volume":"11","author":"N Haji","year":"2020","unstructured":"Haji, N. et al. Tsc1 haploinsufficiency in Nkx2.1 cells upregulates hippocampal interneuron mTORC1 activity, impairs pyramidal cell synaptic inhibition, and alters contextual fear discrimination and spatial working memory in mice. Mol. Autism 11, 29 (2020).","journal-title":"Mol. Autism"},{"key":"688_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06145-8","volume":"7","author":"JD Mills","year":"2017","unstructured":"Mills, J. D. et al. Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment. Sci. Rep. 7, 8089 (2017).","journal-title":"Sci. Rep."},{"key":"688_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.01028","volume":"11","author":"TS Zimmer","year":"2020","unstructured":"Zimmer, T. S. et al. Tuberous sclerosis complex as disease model for investigating mTOR-related gliopathy during epileptogenesis. Front. Neurol. 11, 1028 (2020).","journal-title":"Front. Neurol."},{"key":"688_CR147","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1111\/epi.13923","volume":"58","author":"J Zou","year":"2017","unstructured":"Zou, J., Zhang, B., Gutmann, D. H. & Wong, M. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner. Epilepsia 58, 2053\u20132063 (2017).","journal-title":"Epilepsia"},{"key":"688_CR148","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","volume":"52","author":"PJ de Vries","year":"2015","unstructured":"de Vries, P. J. et al. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. Pediatr. Neurol. 52, 25\u201335 (2015).","journal-title":"Pediatr. Neurol."},{"key":"688_CR149","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ana.26551","volume":"93","author":"AL Cohen","year":"2023","unstructured":"Cohen, A. L. et al. Tubers affecting the fusiform face area are associated with autism diagnosis. Ann. Neurol. 93, 577\u2013590 (2023).","journal-title":"Ann. Neurol."},{"key":"688_CR150","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nature11310","volume":"488","author":"PT Tsai","year":"2012","unstructured":"Tsai, P. T. et al. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488, 647\u2013651 (2012).","journal-title":"Nature"},{"key":"688_CR151","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/s41380-023-02402-7","volume":"29","author":"V Karalis","year":"2024","unstructured":"Karalis, V., Wood, D., Teaney, N. A. & Sahin, M. The role of TSC1 and TSC2 proteins in neuronal axons. Mol. Psychiatry 29, 1165\u20131178 (2024).","journal-title":"Mol. Psychiatry"},{"key":"688_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-019-9293-x","volume":"11","author":"AK Prohl","year":"2019","unstructured":"Prohl, A. K. et al. Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder. J. Neurodev. Disord. 11, 36 (2019).","journal-title":"J. Neurodev. Disord."},{"key":"688_CR153","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.acra.2011.08.016","volume":"19","author":"JM Peters","year":"2012","unstructured":"Peters, J. M. et al. Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex. Acad. Radiol. 19, 17\u201325 (2012).","journal-title":"Acad. Radiol."},{"key":"688_CR154","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","volume":"70","author":"JK Capal","year":"2017","unstructured":"Capal, J. K. et al. Influence of seizures on early development in tuberous sclerosis complex. Epilepsy Behav. 70, 245\u2013252 (2017).","journal-title":"Epilepsy Behav."},{"key":"688_CR155","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26829","author":"S Jozwiak","year":"2023","unstructured":"Jozwiak, S., Kotulska, K., Bebin, E. M. & Krueger, D. A. Commentary regarding the results of the PREVeNT and EPISTOP trials. Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.26829 (2023).","journal-title":"Ann. Neurol."},{"key":"688_CR156","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26778","author":"EM Bebin","year":"2023","unstructured":"Bebin, E. M. et al. Early treatment with vigabatrin does not decrease focal seizures or improve cognition in tuberous sclerosis complex: the PREVeNT trial. Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.26778 (2023).","journal-title":"Ann. Neurol."},{"key":"688_CR157","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.25956","volume":"89","author":"K Kotulska","year":"2021","unstructured":"Kotulska, K. et al. Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial. Ann. Neurol. 89, 304\u2013314 (2021).","journal-title":"Ann. Neurol."},{"key":"688_CR158","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.celrep.2018.09.039","volume":"25","author":"PT Tsai","year":"2018","unstructured":"Tsai, P. T. et al. Sensitive periods for cerebellar-mediated autistic-like behaviors. Cell Rep. 25, 357\u2013367.e4 (2018).","journal-title":"Cell Rep."},{"key":"688_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116664","volume":"44","author":"W Afshar-Saber","year":"2025","unstructured":"Afshar-Saber, W. et al. Neuronal hyperactivity becomes mTORC1 independent due to transcriptional changes in tuberous sclerosis complex disease models. Cell Rep. 44, 116664 (2025).","journal-title":"Cell Rep."},{"key":"688_CR160","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup, H. et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr. Neurol. 123, 50\u201366 (2021). This reports the latest international consensus recommendations for the diagnosis and management of TSC.","journal-title":"Pediatr. Neurol."},{"key":"688_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02277-x","volume":"17","author":"DM Ritter","year":"2022","unstructured":"Ritter, D. M. et al. Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex. Orphanet J. Rare Dis. 17, 124 (2022).","journal-title":"Orphanet J. Rare Dis."},{"key":"688_CR162","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3174\/ajnr.A7952","volume":"44","author":"M Bekiesinska-Figatowska","year":"2023","unstructured":"Bekiesinska-Figatowska, M., Sobieraj, P., Pasieczna, M. & Szymkiewicz-Dangel, J. Early diagnosis of tuberous sclerosis complex: prenatal diagnosis. AJNR Am. J. Neuroradiol. 44, 1070\u20131076 (2023).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"688_CR163","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1177\/088307380001501003","volume":"15","author":"S J\u00f3zwiak","year":"2000","unstructured":"J\u00f3zwiak, S., Schwartz, R. A., Janniger, C. K. & Bielicka-Cymerman, J. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J. Child Neurol. 15, 652\u2013659 (2000).","journal-title":"J. Child Neurol."},{"key":"688_CR164","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejpn.2012.12.008","volume":"17","author":"S J\u00f3\u017awiak","year":"2013","unstructured":"J\u00f3\u017awiak, S., Nabbout, R. & Curatolo, P. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur. J. Paediatr. Neurol. 17, 348\u2013352 (2013).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"688_CR165","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ndt\/gfy063","volume":"34","author":"JC Kingswood","year":"2019","unstructured":"Kingswood, J. C. et al. Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness. Nephrol. Dial. Transpl. 34, 502\u2013508 (2019).","journal-title":"Nephrol. Dial. Transpl."},{"key":"688_CR166","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1164\/ajrccm.164.4.2011025","volume":"164","author":"DN Franz","year":"2001","unstructured":"Franz, D. N. et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am. J. Respir. Crit. Care Med. 164, 661\u2013668 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"688_CR167","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","volume":"51","author":"CJ Chu-Shore","year":"2010","unstructured":"Chu-Shore, C. J., Major, P., Camposano, S., Muzykewicz, D. & Thiele, E. A. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51, 1236\u20131241 (2010).","journal-title":"Epilepsia"},{"key":"688_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2021.06.012","volume":"123","author":"SKZ Ihnen","year":"2021","unstructured":"Ihnen, S. K. Z. et al. Epilepsy is heterogeneous in early-life tuberous sclerosis complex. Pediatr. Neurol. 123, 1\u20139 (2021).","journal-title":"Pediatr. Neurol."},{"key":"688_CR169","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1111\/epi.16379","volume":"60","author":"JY Wu","year":"2019","unstructured":"Wu, J. Y. et al. Scalp EEG spikes predict impending epilepsy in TSC infants: a longitudinal observational study. Epilepsia 60, 2428\u20132436 (2019).","journal-title":"Epilepsia"},{"key":"688_CR170","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/epi.16892","volume":"62","author":"J De Ridder","year":"2021","unstructured":"De Ridder, J. et al. Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes. Epilepsia 62, 1208\u20131219 (2021).","journal-title":"Epilepsia"},{"key":"688_CR171","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/epi4.12286","volume":"4","author":"R Nabbout","year":"2019","unstructured":"Nabbout, R. et al. Epilepsy in tuberous sclerosis complex: findings from the TOSCA study. Epilepsia Open\u00a04, 73\u201384 (2019).","journal-title":"Epilepsia Open"},{"key":"688_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.697467","volume":"12","author":"R Nabbout","year":"2021","unstructured":"Nabbout, R. et al. Historical patterns of diagnosis, treatments, and outcome of epilepsy associated with tuberous sclerosis complex: results from TOSCA Registry. Front. Neurol. 12, 697467 (2021).","journal-title":"Front. Neurol."},{"key":"688_CR173","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.26249","volume":"90","author":"JK Capal","year":"2021","unstructured":"Capal, J. K. et al. Profile of autism spectrum disorder in tuberous sclerosis complex: results from a longitudinal, prospective, multisite study. Ann. Neurol. 90, 874\u2013886 (2021). This large prospective study of autism in infants with TSC confirms that the male-to-female ratio of this diagnosis is close to 1:1.","journal-title":"Ann. Neurol."},{"key":"688_CR174","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0883073807309788","volume":"23","author":"S Jeste","year":"2008","unstructured":"Jeste, S., Sahin, M., Bolton, P., Ploubidis, G. & Humphrey, A. Characterization of autism in young children with tuberous sclerosis complex. J. Child Neurol. 23, 520\u2013525 (2008).","journal-title":"J. Child Neurol."},{"key":"688_CR175","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajmg.c.31637","volume":"178","author":"PJ de Vries","year":"2018","unstructured":"de Vries, P. J. et al. A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). Am. J. Med. Genet. C. Semin. Med Genet 178, 309\u2013320 (2018).","journal-title":"Am. J. Med. Genet. C. Semin. Med Genet"},{"key":"688_CR176","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00467-020-04775-1","volume":"36","author":"P Trnka","year":"2021","unstructured":"Trnka, P. & Kennedy, S. E. Renal tumors in tuberous sclerosis complex. Pediatr. Nephrol. 36, 1427\u20131438 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"688_CR177","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0019-2025","volume":"34","author":"D Elia","year":"2025","unstructured":"Elia, D., Harari, S., Fan, L., Diesler, R. & Henske, E. P. Novel treatment strategies for lymphangioleiomyomatosis: a narrative review. Eur. Respir. Rev. 34, 250019 (2025).","journal-title":"Eur. Respir. Rev."},{"key":"688_CR178","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.ophtha.2012.03.020","volume":"119","author":"ME Aronow","year":"2012","unstructured":"Aronow, M. E., Nakagawa, J. A., Gupta, A., Traboulsi, E. I. & Singh, A. D. Tuberous sclerosis complex: genotype\/phenotype correlation of retinal findings. Ophthalmology 119, 1917\u20131923 (2012).","journal-title":"Ophthalmology"},{"key":"688_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2024.101155","volume":"51","author":"KH Arredondo","year":"2024","unstructured":"Arredondo, K. H., Julich, K. & Roach, E. S. Tuberous sclerosis complex: diagnostic features, surveillance, and therapeutic strategies. Semin. Pediatr. Neurol. 51, 101155 (2024).","journal-title":"Semin. Pediatr. Neurol."},{"key":"688_CR180","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ajhg.2023.04.002","volume":"110","author":"K Klonowska","year":"2023","unstructured":"Klonowska, K. et al. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex. Am. J. Hum. Genet. 110, 979\u2013988 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"688_CR181","doi-asserted-by":"publisher","unstructured":"Alsowat, D. et al. The phenotypic spectrum of tuberous sclerosis complex: a Canadian cohort. Child Neurol. Open https:\/\/doi.org\/10.1177\/2329048X211012817 (2021).","DOI":"10.1177\/2329048X211012817"},{"key":"688_CR182","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000546098","volume":"17","author":"B Tumaini","year":"2025","unstructured":"Tumaini, B., Calori, J. & Ibenzi, E. Challenges in the diagnosis and care of tuberous sclerosis complex in resource-limited settings: a case report from Tanzania. Case Rep. Neurol. 17, 79\u201387 (2025).","journal-title":"Case Rep. Neurol."},{"key":"688_CR183","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1053\/j.ajkd.2025.05.004","volume":"86","author":"EO Valle","year":"2025","unstructured":"Valle, E. O., Guerreiro, M. C., Reusing Junior, J. O., Watanabe, E. H. & Onuchic, L. F. TSC2\/PKD1 contiguous gene deletion syndrome: a case series. Am. J. Kidney Dis. 86, 353\u2013359.e1 (2025).","journal-title":"Am. J. Kidney Dis."},{"key":"688_CR184","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejogrb.2020.03.051","volume":"249","author":"L Zhen","year":"2020","unstructured":"Zhen, L. et al. Prenatal genetic diagnosis of cardiac rhabdomyoma: a single-center experience. Eur. J. Obstet. Gynecol. Reprod. Biol. 249, 7\u201310 (2020).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"688_CR185","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9149(03)00677-5","volume":"92","author":"W Tworetzky","year":"2003","unstructured":"Tworetzky, W. et al. Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am. J. Cardiol. 92, 487\u2013489 (2003).","journal-title":"Am. J. Cardiol."},{"key":"688_CR186","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/197140090702000503","volume":"20","author":"E Jurkiewicz","year":"2007","unstructured":"Jurkiewicz, E., Bekiesinska-Figatowska, M., Romaniuk-Doroszewska, A. & Dangel, J. Brain MRI in fetuses with cardiac tumours. Neuroradiol. J. 20, 494\u2013499 (2007).","journal-title":"Neuroradiol. J."},{"key":"688_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1340271","volume":"11","author":"L Peng","year":"2024","unstructured":"Peng, L. et al. Prenatal diagnosis and clinical management of cardiac rhabdomyoma: a single-center study. Front. Cardiovasc. Med. 11, 1340271 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"688_CR188","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/jamadermatol.2018.1408","volume":"154","author":"M Wataya-Kaneda","year":"2018","unstructured":"Wataya-Kaneda, M. et al. Sirolimus gel treatment vs placebo for facial angiofibromas in patients with tuberous sclerosis complex: a randomized clinical trial. JAMA Dermatol. 154, 781\u2013788 (2018).","journal-title":"JAMA Dermatol."},{"key":"688_CR189","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02982-1","volume":"18","author":"I Cockerell","year":"2023","unstructured":"Cockerell, I. et al. Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice. Orphanet J. Rare Dis. 18, 377 (2023).","journal-title":"Orphanet J. Rare Dis."},{"key":"688_CR190","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1649341","volume":"13","author":"N Muschel","year":"2025","unstructured":"Muschel, N. et al. Drug review: mTOR-inhibitor therapy in fetal cardiac rhabdomyoma \u2014 a tightrope walk. Front. Pediatr. 13, 1649341 (2025).","journal-title":"Front. Pediatr."},{"key":"688_CR191","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaapos.2017.08.009","volume":"22","author":"AB Zipori","year":"2018","unstructured":"Zipori, A. B., Tehrani, N. N. & Ali, A. Retinal astrocytoma regression in tuberous sclerosis patients treated with everolimus. J. AAPOS 22, 76\u201379 (2018).","journal-title":"J. AAPOS"},{"key":"688_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/genes13111932","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. The impact of TSC-1 and -2 mutations on response to therapy in malignant PEComa: a multicenter retrospective analysis. Genes 13, 1932 (2022).","journal-title":"Genes"},{"key":"688_CR193","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.12998\/wjcc.v12.i15.2642","volume":"12","author":"XP Li","year":"2024","unstructured":"Li, X. P. et al. Tuberous sclerosis complex combined with primary lymphedema: a case report. World J. Clin. Cases 12, 2642\u20132648 (2024).","journal-title":"World J. Clin. Cases"},{"key":"688_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03483-4","volume":"25","author":"MW Kluiving","year":"2024","unstructured":"Kluiving, M. W., Peeters, E., Lely, T. A., van Oorschot, N. & de Ranitz-Greven, W. L. The effect of pregnancy on renal angiomyolipoma; a world of knowledge to gain, specifically in women with TSC. BMC Nephrol. 25, 113 (2024).","journal-title":"BMC Nephrol."},{"key":"688_CR195","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.urology.2008.01.067","volume":"72","author":"SA Boorjian","year":"2008","unstructured":"Boorjian, S. A. et al. Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation. Urology 72, 927\u2013932 (2008).","journal-title":"Urology"},{"key":"688_CR196","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger, D. A. & Northrup, H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr. Neurol. 49, 255\u2013265 (2013).","journal-title":"Pediatr. Neurol."},{"key":"688_CR197","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2021.07.010","volume":"123","author":"C Stuart","year":"2021","unstructured":"Stuart, C. et al. Beyond the guidelines: how we can improve healthcare for people with tuberous sclerosis complex around the world. Pediatr. Neurol. 123, 77\u201384 (2021).","journal-title":"Pediatr. Neurol."},{"key":"688_CR198","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/epi.18172","volume":"66","author":"SKZ Ihnen","year":"2025","unstructured":"Ihnen, S. K. Z. et al. Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complex. Epilepsia 66, 117\u2013133 (2025).","journal-title":"Epilepsia"},{"key":"688_CR199","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejpn.2009.03.003","volume":"14","author":"R Bombardieri","year":"2010","unstructured":"Bombardieri, R., Pinci, M., Moavero, R., Cerminara, C. & Curatolo, P. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur. J. Paediatr. Neurol. 14, 146\u2013149 (2010).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"688_CR200","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejpn.2023.08.005","volume":"47","author":"N Specchio","year":"2023","unstructured":"Specchio, N. et al. Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy. Eur. J. Paediatr. Neurol. 47, 25\u201334 (2023).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"688_CR201","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ejpn.2007.03.010","volume":"11","author":"P Parisi","year":"2007","unstructured":"Parisi, P., Bombardieri, R. & Curatolo, P. Current role of vigabatrin in infantile spasms. Eur. J. Paediatr. Neurol. 11, 331\u2013336 (2007).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"688_CR202","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","volume":"78","author":"EA Thiele","year":"2021","unstructured":"Thiele, E. A. et al. Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial. JAMA Neurol. 78, 285\u2013292 (2021).","journal-title":"JAMA Neurol."},{"key":"688_CR203","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14581\/jer.17008","volume":"7","author":"S Park","year":"2017","unstructured":"Park, S. et al. Ketogenic diet for the management of epilepsy associated with tuberous sclerosis complex in children. J. Epilepsy Res. 7, 45\u201349 (2017).","journal-title":"J. Epilepsy Res."},{"key":"688_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108431","volume":"126","author":"X Tong","year":"2022","unstructured":"Tong, X. et al. Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex. Epilepsy Behav. 126, 108431 (2022).","journal-title":"Epilepsy Behav."},{"key":"688_CR205","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3171\/2024.12.PEDS24311","volume":"35","author":"AT Hale","year":"2025","unstructured":"Hale, A. T. et al. Epilepsy surgery outcomes in children with tuberous sclerosis complex: a systematic review and meta-analysis. J. Neurosurg. Pediatr. 35, 599\u2013611 (2025).","journal-title":"J. Neurosurg. Pediatr."},{"key":"688_CR206","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pediatrneurol.2025.07.004","volume":"171","author":"A Gupta","year":"2025","unstructured":"Gupta, A. et al. Epilepsy surgery in tuberous sclerosis complex: a TSC natural history satabase study. Pediatr. Neurol. 171, 28\u201333 (2025).","journal-title":"Pediatr. Neurol."},{"key":"688_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117506","volume":"427","author":"C Vannicola","year":"2021","unstructured":"Vannicola, C. et al. Seizure outcome after epilepsy surgery in tuberous sclerosis complex: results and analysis of predictors from a multicenter study. J. Neurol. Sci. 427, 117506 (2021).","journal-title":"J. Neurol. Sci."},{"key":"688_CR208","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.seizure.2018.06.005","volume":"60","author":"M Fohlen","year":"2018","unstructured":"Fohlen, M. et al. Refractory epilepsy in preschool children with tuberous sclerosis complex: early surgical treatment and outcome. Seizure 60, 71\u201379 (2018).","journal-title":"Seizure"},{"key":"688_CR209","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0901-8","volume":"13","author":"PJ de Vries","year":"2018","unstructured":"de Vries, P. J. et al. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study. Orphanet J. Rare Dis. 13, 157 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"688_CR210","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1212\/WNL.0000000000000568","volume":"83","author":"S Spurling Jeste","year":"2014","unstructured":"Spurling Jeste, S. et al. Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex. Neurology 83, 160\u2013168 (2014).","journal-title":"Neurology"},{"key":"688_CR211","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1212\/WNL.0000000000003002","volume":"87","author":"SS Jeste","year":"2016","unstructured":"Jeste, S. S. et al. Symptom profiles of autism spectrum disorder in tuberous sclerosis complex. Neurology 87, 766\u2013772 (2016).","journal-title":"Neurology"},{"key":"688_CR212","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/IYC.0000000000000160","volume":"33","author":"NM McDonald","year":"2020","unstructured":"McDonald, N. M. et al. Improving developmental abilities in infants with tuberous sclerosis complex: a pilot behavioral intervention study. Infants Young Child. 33, 108\u2013118 (2020).","journal-title":"Infants Young Child."},{"key":"688_CR213","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.sleep.2021.11.010","volume":"89","author":"R Moavero","year":"2022","unstructured":"Moavero, R. et al. Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study. Sleep. Med. 89, 65\u201370 (2022).","journal-title":"Sleep. Med."},{"key":"688_CR214","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-023-09500-1","volume":"15","author":"PJ de Vries","year":"2023","unstructured":"de Vries, P. J. et al. International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). J. Neurodev. Disord. 15, 32 (2023). This paper summarizes the first and the most recent international consensus recommendations related to diagnosis and management of TAND.","journal-title":"J. Neurodev. Disord."},{"key":"688_CR215","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1037\/amp0000904","volume":"77","author":"Guideline Development Panel for the Treatment of Depressive Disorders","year":"2022","unstructured":"Guideline Development Panel for the Treatment of Depressive Disorders Summary of the clinical practice guideline for the treatment of depression across three age cohorts. Am. Psychol. 77, 770\u2013780 (2022).","journal-title":"Am. Psychol."},{"key":"688_CR216","first-page":"5","volume":"164","author":"LM Koran","year":"2007","unstructured":"Koran, L. M. et al. Practice guideline for the treatment of patients with obsessive\u2013compulsive disorder. Am. J. Psychiatry 164, 5\u201353 (2007).","journal-title":"Am. J. Psychiatry"},{"key":"688_CR217","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-2528","volume":"144","author":"ML Wolraich","year":"2019","unstructured":"Wolraich, M. L. et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics 144, e20192528 (2019).","journal-title":"Pediatrics"},{"key":"688_CR218","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jaac.2020.05.005","volume":"59","author":"HJ Walter","year":"2020","unstructured":"Walter, H. J. et al. Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders. J. Am. Acad. Child Adolesc. Psychiatry 59, 1107\u20131124 (2020).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"688_CR219","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pediatrneurol.2023.07.001","volume":"147","author":"TM Heunis","year":"2023","unstructured":"Heunis, T. M. et al. Development and feasibility of the self-report quantified tuberous sclerosis complex-associated neuropsychiatric disorders checklist (TAND-SQ). Pediatr. Neurol. 147, 101\u2013123 (2023).","journal-title":"Pediatr. Neurol."},{"key":"688_CR220","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41390-020-1002-7","volume":"89","author":"DL Chan","year":"2021","unstructured":"Chan, D. L. et al. Congenital subpendymal giant cell astrocytoma in children with tuberous sclerosis complex: growth patterns and neurological outcome. Pediatr. Res. 89, 1447\u20131451 (2021).","journal-title":"Pediatr. Res."},{"key":"688_CR221","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00381-015-2947-4","volume":"32","author":"JD Tsai","year":"2016","unstructured":"Tsai, J. D. et al. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex. Childs Nerv. Syst. 32, 89\u201395 (2016).","journal-title":"Childs Nerv. Syst."},{"key":"688_CR222","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.juro.2016.09.082","volume":"197","author":"JC Warncke","year":"2017","unstructured":"Warncke, J. C. et al. Pediatric renal angiomyolipomas in tuberous sclerosis complex. J. Urol. 197, 500\u2013506 (2017).","journal-title":"J. Urol."},{"key":"688_CR223","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1749-6632.1991.tb37746.x","volume":"615","author":"J Bernstein","year":"1991","unstructured":"Bernstein, J. & Robbins, T. O. Renal involvement in tuberous sclerosis. Ann. NY Acad. Sci. 615, 36\u201349 (1991).","journal-title":"Ann. NY Acad. Sci."},{"key":"688_CR224","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1007\/s00467-022-05820-x","volume":"38","author":"S Gallo-Bernal","year":"2023","unstructured":"Gallo-Bernal, S., Kilcoyne, A., Gee, M. S. & Paul, E. Cystic kidney disease in tuberous sclerosis complex: current knowledge and unresolved questions. Pediatr. Nephrol. 38, 3253\u20133264 (2023).","journal-title":"Pediatr. Nephrol."},{"key":"688_CR225","doi-asserted-by":"publisher","first-page":"S415","DOI":"10.1016\/j.jacr.2020.09.010","volume":"17","author":"Expert Panel on Urologic Imaging","year":"2020","unstructured":"Expert Panel on Urologic Imaging et al. ACR Appropriateness Criteria(R) indeterminate renal mass. J. Am. Coll. Radiol. 17, S415\u2013S428 (2020).","journal-title":"J. Am. Coll. Radiol."},{"key":"688_CR226","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"PT Brook-Carter","year":"1994","unstructured":"Brook-Carter, P. T. et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease \u2014 a contiguous gene syndrome. Nat. Genet. 8, 328\u2013332 (1994).","journal-title":"Nat. Genet."},{"key":"688_CR227","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1148\/radiol.2251011477","volume":"225","author":"K Yamakado","year":"2002","unstructured":"Yamakado, K. et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 225, 78\u201382 (2002).","journal-title":"Radiology"},{"key":"688_CR228","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41581-024-00818-0","volume":"20","author":"D Mekahli","year":"2024","unstructured":"Mekahli, D. et al. Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group. Nat. Rev. Nephrol. 20, 402\u2013420 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"688_CR229","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.euo.2019.04.005","volume":"3","author":"S Fernandez-Pello","year":"2020","unstructured":"Fernandez-Pello, S. et al. Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. Eur. Urol. Oncol. 3, 57\u201372 (2020).","journal-title":"Eur. Urol. Oncol."},{"key":"688_CR230","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s40620-020-00714-3","volume":"34","author":"E Vabret","year":"2021","unstructured":"Vabret, E., Couchoud, C., Lassalle, M. & Vigneau, C. From tuberous sclerosis complex to end stage renal disease: who are these patients. J. Nephrol. 34, 607\u2013615 (2021).","journal-title":"J. Nephrol."},{"key":"688_CR231","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00467-018-4003-6","volume":"33","author":"P Janssens","year":"2018","unstructured":"Janssens, P. et al. Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study. Pediatr. Nephrol. 33, 2085\u20132093 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"688_CR232","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.ekir.2025.04.001","volume":"10","author":"H Sakhi","year":"2025","unstructured":"Sakhi, H. et al. Tuberous sclerosis complex-associated tubulointerstitial kidney disease. Kidney Int. Rep. 10, 2049\u20132053 (2025).","journal-title":"Kidney Int. Rep."},{"key":"688_CR233","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1053\/j.ajkd.2023.04.016","volume":"82","author":"J Kronick","year":"2023","unstructured":"Kronick, J., Gabril, M. Y. & House, A. A. Microscopic kidney disease in tuberous sclerosis complex and treatment with mtor inhibition. Am. J. Kidney Dis. 82, 772\u2013775 (2023).","journal-title":"Am. J. Kidney Dis."},{"key":"688_CR234","doi-asserted-by":"publisher","first-page":"9461","DOI":"10.1158\/0008-5472.CAN-06-1895","volume":"66","author":"J Yu","year":"2006","unstructured":"Yu, J. & Henske, E. P. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain. Cancer Res. 66, 9461\u20139466 (2006).","journal-title":"Cancer Res."},{"key":"688_CR235","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.chest.2023.01.007","volume":"163","author":"N Gupta","year":"2023","unstructured":"Gupta, N. et al. Safety and efficacy of combined resveratrol and sirolimus in lymphangioleiomyomatosis. Chest 163, 1144\u20131155 (2023).","journal-title":"Chest"},{"key":"688_CR236","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.chest.2017.01.033","volume":"151","author":"S El-Chemaly","year":"2017","unstructured":"El-Chemaly, S. et al. Sirolimus and autophagy inhibition in lymphangioleiomyomatosis: results of a phase I clinical trial. Chest 151, 1302\u20131310 (2017).","journal-title":"Chest"},{"key":"688_CR237","doi-asserted-by":"publisher","DOI":"10.3390\/children11060674","volume":"11","author":"C Lazea","year":"2024","unstructured":"Lazea, C., Taranu, I. & Bolboaca, S. D. Exploring cardiovascular involvement in tuberous sclerosis: insights for pediatric clinicians. Children 11, 674 (2024).","journal-title":"Children"},{"key":"688_CR238","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/ajmg.a.62850","volume":"188","author":"LM Evans","year":"2022","unstructured":"Evans, L. M. et al. Tuberous sclerosis complex-associated nonfunctional pancreatic neuroendocrine tumors: management and surgical outcomes. Am. J. Med. Genet. A 188, 2666\u20132671 (2022).","journal-title":"Am. J. Med. Genet. A"},{"key":"688_CR239","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1399-0004.2011.01805.x","volume":"82","author":"AM Larson","year":"2012","unstructured":"Larson, A. M. et al. Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex. Clin. Genet. 82, 558\u2013563 (2012).","journal-title":"Clin. Genet."},{"key":"688_CR240","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00247-016-3701-0","volume":"47","author":"G Koc","year":"2017","unstructured":"Koc, G., Sugimoto, S., Kuperman, R., Kammen, B. F. & Karakas, S. P. Pancreatic tumors in children and young adults with tuberous sclerosis complex. Pediatr. Radiol. 47, 39\u201345 (2017).","journal-title":"Pediatr. Radiol."},{"key":"688_CR241","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1245\/s10434-023-14157-0","volume":"30","author":"S Arya","year":"2023","unstructured":"Arya, S. et al. Long-term outcomes of tuberous sclerosis complex-associated non-functional pancreatic neuroendocrine tumors: should we be more conservative. Ann. Surg. Oncol. 30, 7748\u20137755 (2023).","journal-title":"Ann. Surg. Oncol."},{"key":"688_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2025.162339","volume":"60","author":"R Li","year":"2025","unstructured":"Li, R. et al. Prevalence, characteristics, and management of pancreatic tumors among children with tuberous sclerosis complex. J. Pediatr. Surg. 60, 162339 (2025).","journal-title":"J. Pediatr. Surg."},{"key":"688_CR243","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1399-0004.2012.01845.x","volume":"82","author":"ME Black","year":"2012","unstructured":"Black, M. E. et al. Hepatic manifestations of tuberous sclerosis complex: a genotypic and phenotypic analysis. Clin. Genet. 82, 552\u2013557 (2012).","journal-title":"Clin. Genet."},{"key":"688_CR244","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/ajmg.a.36469","volume":"164A","author":"AL Geffrey","year":"2014","unstructured":"Geffrey, A. L., Shinnick, J. E., Staley, B. A., Boronat, S. & Thiele, E. A. Lymphedema in tuberous sclerosis complex. Am. J. Med. Genet. A 164A, 1438\u20131442 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"688_CR245","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00467-010-1466-5","volume":"25","author":"AE Salerno","year":"2010","unstructured":"Salerno, A. E., Marsenic, O., Meyers, K. E., Kaplan, B. S. & Hellinger, J. C. Vascular involvement in tuberous sclerosis. Pediatr. Nephrol. 25, 1555\u20131561 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"688_CR246","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ajmg.c.31648","volume":"178","author":"S Boronat","year":"2018","unstructured":"Boronat, S. & Barber, I. Less common manifestations in TSC. Am. J. Med. Genet. C. Semin. Med Genet 178, 348\u2013354 (2018).","journal-title":"Am. J. Med. Genet. C. Semin. Med Genet"},{"key":"688_CR247","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.yebeh.2007.07.010","volume":"11","author":"DA Muzykewicz","year":"2007","unstructured":"Muzykewicz, D. A., Newberry, P., Danforth, N., Halpern, E. F. & Thiele, E. A. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav. 11, 506\u2013513 (2007).","journal-title":"Epilepsy Behav."},{"key":"688_CR248","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ejpn.2019.09.006","volume":"23","author":"S Amin","year":"2019","unstructured":"Amin, S., Mallick, A. A., Lux, A. & O\u2019Callaghan, F. Quality of life in patients with tuberous sclerosis complex (TSC). Eur. J. Paediatr. Neurol. 23, 801\u2013807 (2019).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"688_CR249","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00904","volume":"11","author":"AC Jansen","year":"2020","unstructured":"Jansen, A. C. et al. Burden of illness and quality of life in tuberous sclerosis complex: findings from the TOSCA study. Front. Neurol. 11, 904 (2020).","journal-title":"Front. Neurol."},{"key":"688_CR250","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/cns.13473","volume":"27","author":"Y Ding","year":"2021","unstructured":"Ding, Y. et al. Quality of life in children with tuberous sclerosis complex: a pediatric cohort study. CNS Neurosci. Ther. 27, 280\u2013288 (2021).","journal-title":"CNS Neurosci. Ther."},{"key":"688_CR251","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","volume":"363","author":"DA Krueger","year":"2010","unstructured":"Krueger, D. A. et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N. Engl. J. Med. 363, 1801\u20131811 (2010).","journal-title":"N. Engl. J. Med."},{"key":"688_CR252","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamadermatol.2018.0464","volume":"154","author":"MK Koenig","year":"2018","unstructured":"Koenig, M. K. et al. Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex: the TREATMENT randomized clinical trial. JAMA Dermatol. 154, 773\u2013780 (2018).","journal-title":"JAMA Dermatol."},{"key":"688_CR253","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-022-09423-3","volume":"14","author":"S Vanclooster","year":"2022","unstructured":"Vanclooster, S. et al. The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) \u2014 a comprehensive scoping review. J. Neurodev. Disord. 14, 13 (2022).","journal-title":"J. Neurodev. Disord."},{"key":"688_CR254","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/acn3.494","volume":"4","author":"DA Krueger","year":"2017","unstructured":"Krueger, D. A. et al. Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders. Ann. Clin. Transl. Neurol. 4, 877\u2013887 (2017).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"688_CR255","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","volume":"93","author":"IE Overwater","year":"2019","unstructured":"Overwater, I. E. et al. A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology 93, e200\u2013e209 (2019).","journal-title":"Neurology"},{"key":"688_CR256","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nbd.2015.04.018","volume":"82","author":"S Prabhakar","year":"2015","unstructured":"Prabhakar, S. et al. Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model. Neurobiol. Dis. 82, 22\u201331 (2015).","journal-title":"Neurobiol. Dis."},{"key":"688_CR257","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.omtm.2019.08.003","volume":"15","author":"S Prabhakar","year":"2019","unstructured":"Prabhakar, S. et al. Long-term therapeutic efficacy of intravenous AAV-mediated hamartin replacement in mouse model of tuberous sclerosis type 1. Mol. Ther. Methods Clin. Dev. 15, 18\u201326 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"688_CR258","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb1703","volume":"7","author":"PS Cheah","year":"2021","unstructured":"Cheah, P. S. et al. Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin. Sci. Adv. 7, eabb1703 (2021).","journal-title":"Sci. Adv."},{"key":"688_CR259","doi-asserted-by":"publisher","unstructured":"Wong, S. N. et al. Cerebral organoids uncover mechanisms of neural activity changes in epileptogenesis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.08.26.672285 (2025).","DOI":"10.1101\/2025.08.26.672285"},{"key":"688_CR260","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1522652","volume":"18","author":"KD Winden","year":"2024","unstructured":"Winden, K. D., Gisser, I. & Sahin, M. Using cortical organoids to understand the pathogenesis of malformations of cortical development. Front. Neurosci. 18, 1522652 (2024).","journal-title":"Front. Neurosci."},{"key":"688_CR261","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf5546","volume":"375","author":"OL Eichmuller","year":"2022","unstructured":"Eichmuller, O. L. et al. Amplification of human interneuron progenitors promotes brain tumors and neurological defects. Science 375, eabf5546 (2022).","journal-title":"Science"},{"key":"688_CR262","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41436-020-0823-4","volume":"22","author":"B Ogorek","year":"2020","unstructured":"Ogorek, B. et al. TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study. Genet. Med. 22, 1489\u20131497 (2020).","journal-title":"Genet. Med."},{"key":"688_CR263","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo, P., Moavero, R. & de Vries, P. J. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 14, 733\u2013745 (2015).","journal-title":"Lancet Neurol."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00688-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:01:36Z","timestamp":1773302496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00688-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":263,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1038\/s41572-026-00688-9","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"16 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.M.B. declares currently active membership of scientific advisory boards for Apertura Gene Therapy and Cassava Sciences Inc. S.J. declares membership of the safety monitoring committee for Ionis Pharmaceuticals (Angelman syndrome ASO phase II trial). D.A.K. declares membership of scientific advisory boards for Jazz Pharmaceuticals and Aeovian Pharmaceuticals, and grant support from Jazz Pharmaceuticals. M.S. declares membership of scientific advisory boards for Neurogene and Noema; chairmanship of the scientific advisory board for PTEN Research; and\u00a0grant support from Biogen, Gondalobio and\u00a0Neurvati. K.W. and E.P. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}